Application of “Omics” Technologies to In Vitro Toxicology
| dc.contributor.author | Stiegler, Nina | |
| dc.contributor.author | Dao, Tyna | |
| dc.contributor.author | Leist, Marcel | |
| dc.contributor.author | Voijnits, Kinga | |
| dc.contributor.author | Waldmann, Tanja | |
| dc.contributor.author | Zhao, Liang | |
| dc.contributor.author | Hogberg, Helena T. | |
| dc.contributor.author | van Vliet, Erwin | |
| dc.date.accessioned | 2015-03-04T11:00:47Z | |
| dc.date.available | 2015-03-04T11:00:47Z | |
| dc.date.issued | 2014 | eng |
| dc.description.abstract | “Omics” technologies have facilitated significant advances in the understanding of toxicity mechanisms in complex biological systems. In this chapter we discuss the most important “omics” technologies and how they are currently applied in the field of in vitro toxicology. For each technology, advantages, limitations, and developmental needs are addressed. In addition, we provide some future prospects on the role of “omics” technologies in the emerging new paradigm of mechanistic toxicity studies. It becomes clear that technological developments have enhanced the application of “omics” technologies in toxicology and simplified the interpretation of the generated information; nevertheless, significant challenges remain to incorporate “omics” technologies and “omics” data in the regulatory decision making process. | eng |
| dc.description.version | published | |
| dc.identifier.doi | 10.1007/978-1-4939-0521-8_18 | eng |
| dc.identifier.uri | http://kops.uni-konstanz.de/handle/123456789/30151 | |
| dc.language.iso | eng | eng |
| dc.subject | Transcriptomics, Proteomics, Metabolomics, Epigenetics, Systems biology | eng |
| dc.subject.ddc | 570 | eng |
| dc.title | Application of “Omics” Technologies to In Vitro Toxicology | eng |
| dc.type | INCOLLECTION | eng |
| dspace.entity.type | Publication | |
| kops.citation.bibtex | @incollection{Stiegler2014Appli-30151,
year={2014},
doi={10.1007/978-1-4939-0521-8_18},
title={Application of “Omics” Technologies to In Vitro Toxicology},
number={1557-2153},
isbn={978-1-4939-0520-1},
publisher={Springer},
address={New York},
series={Methods in Pharmacology and Toxicology},
booktitle={In Vitro Toxicology Systems},
pages={399--432},
editor={Anna Bal-Price ...},
author={Stiegler, Nina and Dao, Tyna and Leist, Marcel and Voijnits, Kinga and Waldmann, Tanja and Zhao, Liang and Hogberg, Helena T. and van Vliet, Erwin}
} | |
| kops.citation.iso690 | STIEGLER, Nina, Tyna DAO, Marcel LEIST, Kinga VOIJNITS, Tanja WALDMANN, Liang ZHAO, Helena T. HOGBERG, Erwin VAN VLIET, 2014. Application of “Omics” Technologies to In Vitro Toxicology. In: ANNA BAL-PRICE ..., , ed.. In Vitro Toxicology Systems. New York: Springer, 2014, pp. 399-432. Methods in Pharmacology and Toxicology. 1557-2153. ISBN 978-1-4939-0520-1. Available under: doi: 10.1007/978-1-4939-0521-8_18 | deu |
| kops.citation.iso690 | STIEGLER, Nina, Tyna DAO, Marcel LEIST, Kinga VOIJNITS, Tanja WALDMANN, Liang ZHAO, Helena T. HOGBERG, Erwin VAN VLIET, 2014. Application of “Omics” Technologies to In Vitro Toxicology. In: ANNA BAL-PRICE ..., , ed.. In Vitro Toxicology Systems. New York: Springer, 2014, pp. 399-432. Methods in Pharmacology and Toxicology. 1557-2153. ISBN 978-1-4939-0520-1. Available under: doi: 10.1007/978-1-4939-0521-8_18 | eng |
| kops.citation.rdf | <rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/30151">
<dcterms:title>Application of “Omics” Technologies to In Vitro Toxicology</dcterms:title>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:creator>Zhao, Liang</dc:creator>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-03-04T11:00:47Z</dcterms:available>
<dc:creator>van Vliet, Erwin</dc:creator>
<dc:contributor>Dao, Tyna</dc:contributor>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:creator>Voijnits, Kinga</dc:creator>
<dcterms:issued>2014</dcterms:issued>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dc:creator>Leist, Marcel</dc:creator>
<dc:creator>Dao, Tyna</dc:creator>
<dc:creator>Stiegler, Nina</dc:creator>
<dc:contributor>Stiegler, Nina</dc:contributor>
<dc:contributor>Hogberg, Helena T.</dc:contributor>
<dcterms:abstract xml:lang="eng">“Omics” technologies have facilitated significant advances in the understanding of toxicity mechanisms in complex biological systems. In this chapter we discuss the most important “omics” technologies and how they are currently applied in the field of in vitro toxicology. For each technology, advantages, limitations, and developmental needs are addressed. In addition, we provide some future prospects on the role of “omics” technologies in the emerging new paradigm of mechanistic toxicity studies. It becomes clear that technological developments have enhanced the application of “omics” technologies in toxicology and simplified the interpretation of the generated information; nevertheless, significant challenges remain to incorporate “omics” technologies and “omics” data in the regulatory decision making process.</dcterms:abstract>
<dc:creator>Hogberg, Helena T.</dc:creator>
<dc:language>eng</dc:language>
<dc:contributor>Waldmann, Tanja</dc:contributor>
<dc:creator>Waldmann, Tanja</dc:creator>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dc:contributor>van Vliet, Erwin</dc:contributor>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-03-04T11:00:47Z</dc:date>
<dc:contributor>Voijnits, Kinga</dc:contributor>
<dc:contributor>Leist, Marcel</dc:contributor>
<bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/30151"/>
<dc:contributor>Zhao, Liang</dc:contributor>
</rdf:Description>
</rdf:RDF> | |
| kops.flag.knbibliography | true | |
| kops.sourcefield | ANNA BAL-PRICE ..., , ed.. <i>In Vitro Toxicology Systems</i>. New York: Springer, 2014, pp. 399-432. Methods in Pharmacology and Toxicology. 1557-2153. ISBN 978-1-4939-0520-1. Available under: doi: 10.1007/978-1-4939-0521-8_18 | deu |
| kops.sourcefield.plain | ANNA BAL-PRICE ..., , ed.. In Vitro Toxicology Systems. New York: Springer, 2014, pp. 399-432. Methods in Pharmacology and Toxicology. 1557-2153. ISBN 978-1-4939-0520-1. Available under: doi: 10.1007/978-1-4939-0521-8_18 | deu |
| kops.sourcefield.plain | ANNA BAL-PRICE ..., , ed.. In Vitro Toxicology Systems. New York: Springer, 2014, pp. 399-432. Methods in Pharmacology and Toxicology. 1557-2153. ISBN 978-1-4939-0520-1. Available under: doi: 10.1007/978-1-4939-0521-8_18 | eng |
| relation.isAuthorOfPublication | e9c0c8cd-cc4a-40b8-bec3-ad73b687602f | |
| relation.isAuthorOfPublication | d166cc79-683e-4b5f-b4a0-8ccdd3d02bbc | |
| relation.isAuthorOfPublication | 22439442-4599-40bc-93f9-1ca7b69b0787 | |
| relation.isAuthorOfPublication.latestForDiscovery | e9c0c8cd-cc4a-40b8-bec3-ad73b687602f | |
| source.bibliographicInfo.fromPage | 399 | eng |
| source.bibliographicInfo.seriesNumber | 1557-2153 | eng |
| source.bibliographicInfo.toPage | 432 | eng |
| source.contributor.editor | Anna Bal-Price ... | eng |
| source.identifier.isbn | 978-1-4939-0520-1 | eng |
| source.publisher | Springer | eng |
| source.publisher.location | New York | eng |
| source.relation.ispartofseries | Methods in Pharmacology and Toxicology | eng |
| source.title | In Vitro Toxicology Systems | eng |
| temp.internal.duplicates | <p>Keine Dubletten gefunden. Letzte Überprüfung: 08.12.2014 16:05:16</p> | deu |